Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Arthritis and Rheumatism|August 29, 2013
Anti-tumor necrosis factor α targets protein kinase B/c-Akt-induced resistance of effector cells to suppression in juvenile idiopathic arthritisEllen J Wehrens, Sebastiaan J Vastert, Gerdien Mijnheer, et al.
Rheumatology (Oxford, England)|April 17, 2015
Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritisMaja Bulatović Ćalasan, Sebastiaan J Vastert, Rianne C Scholman, et al.
Rheumatology (Oxford, England)|November 27, 2019
Anakinra in children and adults with Still's diseaseSebastiaan J Vastert, Yvan Jamilloux, Pierre Quartier, et al.
Pediatric Rheumatology Online Journal|December 30, 2025
Adoption of new treatment options in non-systemic juvenile idiopathic arthritis (JIA) in clinical practiceHedda C Lamers, Erika Van Nieuwenhove, Sebastiaan J Vastert, et al.
The Patient|June 9, 2026
Responsiveness of the EQ-5D-Y-5L Parent-Proxy Version Among Children with Juvenile Idiopathic ArthritisDeborah A Marshall, Jiabi Wen, Gillian R Currie, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 14, 2024
Validation of the EQ-5D-Y-5L parent-proxy version among children with juvenile idiopathic arthritisArto Ohinmaa, Jiabi Wen, Gillian R Currie, et al.
Annals of the Rheumatic Diseases|November 30, 2013
Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patientsMaja Bulatović Ćalasan, Ethan den Boer, Maurits C F J de Rotte, et al.
Pediatrics|January 29, 2014
Periodic fever in MVK deficiency: a patient initially diagnosed with incomplete Kawasaki diseaseValtyr S Thors, Sebastiaan J Vastert, Nico Wulffraat, et al.
European Journal of Immunology|March 8, 2011
FOXP3+ CD4+ Tregs lose suppressive potential but remain anergic during transient inflammation in humanAlvin W L Schadenberg, Sebastiaan J Vastert, Fabiola C M Evens, et al.
Pharmaceuticals (Basel, Switzerland)|January 11, 2019
Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Anxiety, and DepressionGerdien A H Korte-Bouws, Eline Albers, Marije Voskamp, et al.
Pageof 9